KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Non-Current Assets: 2010-2024

Historic Other Non-Current Assets for Emergent BioSolutions (EBS) over the last 14 years, with Dec 2024 value amounting to $18.9 million.

  • Emergent BioSolutions' Other Non-Current Assets rose 78.46% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 78.46%. This contributed to the annual value of $18.9 million for FY2024, which is 90.27% down from last year.
  • As of FY2024, Emergent BioSolutions' Other Non-Current Assets stood at $18.9 million, which was down 90.27% from $194.3 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Other Non-Current Assets ranged from a high of $194.3 million in FY2023 and a low of $18.9 million during FY2024.
  • Its 2-year average for Other Non-Current Assets is $106.6 million, with a median of $106.6 million in 2023.
  • Per our database at Business Quant, Emergent BioSolutions' Other Non-Current Assets increased by 25.58% in 2020 and then slumped by 90.27% in 2024.
  • Over the past 4 years, Emergent BioSolutions' Other Non-Current Assets (Yearly) stood at $113.4 million in 2020, then tumbled by 48.68% to $58.2 million in 2021, then reached $194.3 million in 2023, then crashed by 90.27% to $18.9 million in 2024.